Author:
Rao Jasti S.,Suzuki Riichiro,Festoff Barry W.
Reference48 articles.
1. G. Girmann, H. Pees, and G. Schwarze, Immunosuppression by micromolecular fibrinogen degradation products in cancer, Nature 259: 339–401 (1976).
2. E.F. Plow, D. Freaney, and T.S. Edgington, Inhibition of lymphocyte protein synthesis by fibrinogen-derived peptides, J ImmunoL 128: 1595–1599 (1982).
3. R. Ng, and JA. Kellen, The role of plasminogen activators in metastasis, Med. Hypothesis 10: 291293 (1983).
4. NA. Booth, R. Bennett, and G. Wijngaards, A new lifelong hemorrhage disorder due to excess plasminogen activator, Blood 61: 269–275 (1983).
5. A. Carrel, and M.T. Burrows, Cultivation in vitro of malignant tumors, J. Exp. Med. 13: 571–575 (1911).